Epigenetic plasticity and the hallmarks of cancer

Flavahan, William A., Gaskell, Elizabeth, Bernstein, Bradley E.·2017·Science

DOI 10.1126/science.aal2380

Cited by (1,001)

Items 701–800 of 1,001

Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Martina Taglieri, Linda Di Gregorio, Serena Matis, Chiara Rosa Maria Uras, Massimo Ardy, Sara Casati, Monica Marchese, Alessandro Delli Poggi, Lizzia Raffaghello, Roberto Benelli · 2025 · Cells
Always on the Move: Overview on Chromatin Dynamics within Nuclear Processes
Charlotte M. Delvaux de Fenffe, Jolijn Govers, Francesca Mattiroli · 2025 · Biochemistry
Cancer progression through the lens of age-induced metabolic reprogramming
Felicia Lazure, Ana P. Gomes · 2025 · Nature reviews. Cancer
Lactylation: A new direction for tumor-targeted therapy
Dan Deng, Yan Luo, Yun Hong, Xing Ren, Xuyu Zu, Jianbo Feng · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
A primer on recent developments in cancer immunotherapy, with a focus on neoantigen vaccines
Taku A. Tokuyasu, Jian‐Dong Huang · 2018 · Journal of Cancer Metastasis and Treatment
Can aggressive cancers be identified by the “aggressiveness” of their chromatin?
Katerina V. Gurova · 2022 · BioEssays
Chromosomal Heteromorphisms and Cancer Susceptibility Revisited
Thomas Liehr · 2022 · Cells
Dose rate dependent reduction in chromatin accessibility at transcriptional start sites long time after exposure to gamma radiation
Hildegunn Dahl, Jarle Ballangby, Torstein Tengs, Marcin Wlodzimierz Wojewodzic, Dag M. Eide, Dag Anders Brede, Anne Graupner, Nur Duale, Ann-Karin Hardie Olsen · 2023 · Epigenetics
High Glucose Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in A20 Murine Diﬀuse Large B-Cell Lymphoma Cells Through Increased Expression of High Mobility Group AT-Hook 2 (HMGA2)
Ya Wang, Jie Tan, Hongyan Wu, Cunjian Yi · 2019 · Medical Science Monitor
Principles and methods of integrative chromatin analysis in primary tissues and tumors
Paloma Cejas, Henry W. Long · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Edgetic perturbation signatures represent known and novel cancer biomarkers
Evans Sioma Kataka, Jan Maciej Zaucha, Goar Frishman, Andreas Ruepp, Dmitrij Frishman · 2020 · Scientific Reports
Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM
Dao wei Zhang, Shenghai Zhang, Jihong Wu · 2020 · PeerJ
RB1, Cancer Lineage Plasticity, and Therapeutic Resistance
Letian Zhang, David W. Goodrich · 2022 · Annual Review of Cancer Biology
The Contributions of Cancer-Testis and Developmental Genes to the Pathogenesis of Keratinocyte Carcinomas
Brandon Liam Ramchatesingh, Jennifer K. Gantchev, Amelia Martínez Villarreal, Raman Preet Kaur Gill, Marine Lambert, Sriraam Sivachandran, Philippe Lefrançois, Ivan V. Litvinov · 2022 · Cancers
Cancer – A devastating disease, but also an eye-opener and window into the deep mysteries of life and its origins
Thomas W. Grunt, Peter Valent · 2022 · Progress in Biophysics and Molecular Biology
Downregulation of long non-protein coding RNA MVIH impairs glioblastoma cell proliferation and invasion through an miR-302a-dependent mechanism
Ana Maria Cardoso, Catarina M. Morais, Olinda Rebelo, Hermínio Tão, Marcos Barbosa, Maria C. Pedroso de Lima, Amália S. Jurado · 2021 · Human Molecular Genetics
Lineage Recording Reveals the Phylodynamics, Plasticity and Paths of Tumor Evolution
Dian Yang, Matthew G. Jones, Santiago Naranjo, William M. Rideout, Kyung Hoi Min, Raymond Ho, Wei Wu, Joseph M. Replogle, Jennifer L. Page, Jeffrey J. Quinn et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Evolutionary dynamics in the decades preceding acute myeloid leukaemia
Caroline J. Watson, Gladys Y. P. Poon, Hamish A J MacGregor, Adriana V.A. Fonseca, Sophia Apostolidou, Aleksandra Gentry‐Maharaj, Usha Menon, Jamie R. Blundell · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
Mamiko Tosa, Yoshinori Abe, Seiko Egawa, Tomoka Hatakeyama, Chihiro Iwaguro, Ryotaro Mitsugi, Ayaka Moriyama, Takumi Sano, Rei Ogawa, Nobuyuki Tanaka · 2023 · Communications Biology
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells
Xu He, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xianjun Yu, Si Shi · 2024 · Science Advances
LncRNAs in melanoma phenotypic plasticity: emerging targets for promising therapies
Beatriz Cristina Biz Tonin, Castro-Silva Carolina de Sousa, Slack Frank John, Miriam Galvonas Jasiulionis · 2024 · RNA Biology
Association of epigenetic landscapes with heterogeneity and plasticity in pancreatic cancer
Paul Manoukian, Leo C Kuhnen, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma · 2024 · Critical Reviews in Oncology/Hematology
The accuracy of DNA methylation detection in endometrial cancer screening: A systematic review and meta‐analysis
Ran Ran, Ming Wang, Jinwei Miao · 2024 · International Journal of Gynecology & Obstetrics
Application of an Integrated Single-Cell and Three-Dimensional Spheroid Culture Platform for Investigating Drug Resistance Heterogeneity and Epithelial–Mesenchymal Transition (EMT) in Lung Cancer Subclones
Shin-Hu Chen, Jian-Hong Yu, Yu‐Chun Lin, Yi-Ming Chang, Nien-Tzu Liu, Su-Feng Chen · 2025 · International Journal of Molecular Sciences
The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs
Qianqian Yang, Zihan Zhou, Lian Li, Runhui Lu, Guofang Hou, Caihu Huang, Jiayi Huang, Hongyan Li, Yafan Zhang, Jiayong Li et al. · 2025 · Nucleic Acids Research
Non-canonical extracellular complement pathways and the complosome paradigm in cancer: a scoping review
Camila F. Oliveira, Amarilis Giaretta de Moraes, Helena Musetti B. S. Plácido, Nathalia M D L Signorini, Pâmela Dias Fontana, Tatiane da Piedade Batista Godoy, Angelica Beate Winter Boldt, Iara Messias-Reason · 2025 · Frontiers in Immunology
Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer Differentiation
Pornlada Likasitwatanakul, Zhixin Li, Khoa Tat Doan, Sándor Spisák, Akhouri Kishore Raghawan, Qi Liu, Priscilla Liow, Sunwoo Liv Lee, David J. Chen, Pratyusha Bala et al. · 2025 · Gastroenterology
Metabolism and epigenetics in cancer: toward personalized treatment
Xiaoman Zhang, Dequan Liu, Sulan Yin, Yaru Gao, Xiaorui Li, Guangzhen Wu · 2025 · Frontiers in Endocrinology
KCTD10 is a sensor for co-directional transcription–replication conflicts
Jake A. Kloeber, Bin Chen, Guangchao Sun, Charles S. King, Zhiquan Wang, Li Wang, Zheming Wu, Shouhai Zhu, Fei Zhao, Hongran Qin et al. · 2025 · Nature
Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications
Hina Sultana, Abhishikt David Solomon, Atif Khurshid Wani, Surendra Kumar Shukla · 2025 · Frontiers in Epigenetics and Epigenomics
5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer
Fabio Puddu, Annelie Johansson, Aurélie Modat, Jamie Scotcher, Riccha Sethi, Shirong Yu, Nick Harding, Mark S. Hill, Ermira Lleshi, Casper K. Lumby et al. · 2026 · Communications Medicine
Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance
Ji‐Yong Sung, Kihwan Hwang · 2026 · Molecular Biomedicine
Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death
Amandda Évelin Silva-Carvalho, Ana Paula Dorneles Alencar, Marielly Reis Resende, Daniel Freitas da Costa, Alexandre Nonino, Francisco Assis Rocha Neves, Felipe Saldanha‐Araújo · 2020 · Toxicology in Vitro
Aberrant transcription factors in the cancers of the pancreas
Md. Hafiz Uddin, Md Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel F. El‐Rayes, Asfar Sohail Azmi · 2022 · Seminars in Cancer Biology
Transcriptomic Maps of Colorectal Liver Metastasis: Machine Learning of Gene Activation Patterns and Epigenetic Trajectories in Support of Precision Medicine
Ohanes Ashekyan, Nerses Shahbazyan, Yeva Bareghamyan, A. V. Kudryavzeva, Daria Mandel, Maria Schmidt, Henry Loeffler‐Wirth, Mohamed Uduman, Dhan Sidhartha Chand, Dennis J. Underwood et al. · 2023 · Cancers
A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation
Hira Javaid, Alessandro Barberis, Olga Chervova, Isar Nassiri, Vitaly Voloshin, Yusuke Sato, Seishi Ogawa, Benjamin Peter Fairfax, Francesca Meteora Buffa, Timothy C. Humphrey · 2023 · BMC Cancer
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease
Carolina Caserta, Silvia Nucera, Matteo Barcella, Grazia Fazio, Matteo Maria Naldini, Riccardo Pagani, Francesca Pavesi, Giacomo Desantis, Erika Zonari, Mariella D’Angiò et al. · 2023 · Leukemia
Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases
Fei Mao, Yujiang Geno Shi · 2023 · Advances in experimental medicine and biology
Deciphering cellular plasticity in pancreatic cancer for effective treatments
Md. Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F. El‐Rayes, Herbert Chen, Philip A. Philip, Asfar Sohail Azmi · 2024 · Cancer and Metastasis Reviews
Adaptive Control of Tumor Growth
Youcef Derbal · 2024 · Cancer Control
Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults
Floris P Barthel, Kevin C. Johnson, Pieter Wesseling, Roel G.W. Verhaak · 2018 · Neurologic Clinics
Targeting Epigenetic Dependencies in Solid Tumors: Evolutionary Landscape Beyond Germ Layers Origin
Francesca Citron, Linda Fabris · 2020 · Cancers
Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia
Oriol de Barrios, Maribel Parra · 2021 · International Journal of Molecular Sciences
Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma
Yanming Chen, Ye Wang, Qiheng He, Wen Wang, Tan Zhang, Zhongyong Wang, Jun Dong, Qing Lan, Jizong Zhao · 2021 · Cancer Medicine
Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
Haydee M. Torres, Ashley M. VanCleave, Mykayla L Vollmer, Dakota Callahan, Austyn Smithback, Josephine M. Conn, Tania G. Rodezno, Zili Gao, Yuxia X. Cao, Yohannes Afeworki Tecleab et al. · 2021 · Cancers
Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma
Tiziana Servidei, Donatella Lucchetti, Pierluigi Navarra, Alessandro Sgambato, Riccardo Riccardi, Antonio Ruggiero · 2021 · Cancers
The Transcriptome and Methylome of the Developing and Aging Brain and Their Relations to Gliomas and Psychological Disorders
Henry Loeffler‐Wirth, Lydia Hopp, Maria Schmidt, Roksana Zakharyan, Arsen Arakelyan, Hans Binder · 2022 · Cells
It’s all in the combination: decoding the epigenome for cancer research and diagnostics
Noa Furth, Efrat Shema · 2022 · Current Opinion in Genetics & Development
ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes
Fei‐Yuan Yu, Qian Xu, Qi-Yao Wei, Hai-Ying Mo, Qiu-Hua Zhong, Xiao-Yun Zhao, Andy T. Y. Lau, Yan‐Ming Xu · 2022 · Journal of Cancer Research and Clinical Oncology
Scales of Cancer Evolution: Selfish Genome or Cooperating Cells?
B. Brutovský · 2022 · Cancers
Genetics and epigenetics in conventional chondrosarcoma with focus on non-coding RNAs
Albert Roessner, Sabine Franke, Julian Schreier, Sarah Rebecca Ullmann, Franziska Karras, Dörthe Jechorek · 2022 · Pathology - Research and Practice
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives
Ugo Chianese, Chiara Papulino, Wout Megchelenbrink, Francesco Paolo Tambaro, Fortunato Ciardiello, Rosaria Benedetti, Lucia Altucci · 2023 · Seminars in Cancer Biology
Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms
Ornella Affinito, Paolo Salerno, Alfonso Manuel D’Alessio, Mariella Cuomo, Ermanno Florio, Francesca Carlomagno, Agnese Proietti, Riccardo Giannini, Fulvio Basolo, Lorenzo Chiariotti et al. · 2019 · Endocrine Related Cancer
Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer
Bin Lian, Hong Li, Yaobang Liu, Dahai Chai, Yali Gao, Yangyang Zhang, Jia Zhou, Jin‐Ping Li · 2020 · Breast Cancer
Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers
Karen J. Meaburn, Tom Misteli · 2019 · Frontiers in Genetics
Liquid biopsies for early cancer detection
Stefan H. Bossmann · 2020 · Elsevier eBooks
Copy number-aware deconvolution of tumor-normal DNA methylation profiles
Elizabeth Larose Cadieux, Nana Mensah, Carla Castignani, Miljana Tanić, Gareth A. Wilson, Michelle Dietzen, Pawan Dhami, Heli Vaikkinen, Annelien Verfaillie, Cristina Cotobal et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Scrutinizing the landscape of DNA methylation epigenetic face(s) in glioblastomas
Nadia Μ. Hamdy, Mariam M. Gabr, Sherihan G. AbdelHamid, Menha M. Swellam · 2024 · Elsevier eBooks
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations
Valentina Masciale, Federico Banchelli, Giulia Grisendi, Anna Valeria Samarelli, Giulia Raineri, Tania Rossi, Michele Zanoni, Michela Cortesi, Sara Bandini, Paola Ulivi et al. · 2024 · Journal of Biological Chemistry
USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability
Pu Wu, Wanting Xiao, Junjie Ni, Yuming Lou, Chaoyang Xu · 2025 · Cancer Biology & Therapy
Epigenetic regulation of the tumor microenvironment in lung cancer: mechanism insights and therapeutic prospects
Maoqin Yang, Xudong Lei, Dexiang Ren, Dakai Qin, Xiaojun Xia · 2025 · Frontiers in Immunology
Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Alejandro Jiménez-Sánchez, Sitara Persad, Akimasa Hayashi, Shigeaki Umeda, Roshan Sharma, Yubin Xie, Arnav Mehta, Wungki Park, Ignas Masilionis, Tinyi Chu et al. · 2025 · Cancer Research
The Epigenetic Cytocrin Pathway to the Nucleus. Epigenetic Factors, Epigenetic Mediators, and Epigenetic Traits. A Biochemist Perspective
Gemma Navarro, Nuria Franco, Eva Martínez‐Pinilla, Rafael Franco · 2017 · Frontiers in Genetics
Why ACE—overview of the development of the subtype-selective histone deacetylase inhibitor chidamide in hormone receptor positive advanced breast cancer
Zhiqiang Ning · 2020 · Translational Breast Cancer Research
Exploring the Eco-Evolutionary Dynamics of Tumor Subclones
Theodoros N Rampias · 2020 · Cancers
Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance
Zhiquan Wang, Rentian Wu, Qian Nie, Kelly J. Bouchonville, Robert B. Diasio, Steven M. Offer · 2021 · Journal of the National Cancer Center
Chromatin state transitions in the Drosophila intestinal lineage identify principles of cell-type specification
Manon Josserand, Natalia Rubanova, Marine Stefanutti, Spyridon Roumeliotis, Marion Espenel, Owen J. Marshall, Nicolas Servant, Louis Gervais, Allison J. Bardin · 2023 · Developmental Cell
Single‐cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild‐type glioma
Jinwei Li, Shengrong Long, Yang Zhang, Wei Wei, Shuangqi Yu, Quan Liu, Xuhui Hui, Xiang Li, Yinyan Wang · 2024 · MedComm
Cancer, Mankind′s Challenge
Ying‐Yu Cui · 2019 · Current Cancer Reports
LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?
Shaun Egolf, Brian C. Capell · 2020 · Expert Opinion on Therapeutic Targets
The Hippo pathway coactivator Yorkie can reprogram cell fates and create compartment-boundary–like interactions at clone margins
Joanna Carmen Downes Bairzin, Maya Emmons‐Bell, Iswar K. Hariharan · 2020 · Science Advances
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK–driven lymphomagenesis
Elisa Redl, Raheleh Sheibani‐Tezerji, Crhistian de Jesus Cardona, Patricia Hamminger, Gerald Timelthaler, Melanie R. Hassler, Maša Zrimšek, Sabine Lagger, Thomas Dillinger, Lorena Hofbauer et al. · 2020 · Life Science Alliance
Reconsidering LINE-1’s role in cancer: does LINE-1 function as a reporter detecting early cancer-associated epigenetic signatures?
Maxfield M. G. Kelsey · 2021 · Evolution Medicine and Public Health
Spike-in normalization for single-cell RNA-seq reveals dynamic global transcriptional activity mediating anticancer drug response
Xin Wang, Jane Frederick, Hongbin Wang, Sheng Hui, Vadim Backman, Zhe Ji · 2021 · NAR Genomics and Bioinformatics
Bridging Tumorigenesis and Therapy Resistance With a Non-Darwinian and Non-Lamarckian Mechanism of Adaptive Evolution
Francesco Catania, Beáta Újvári, Benjamín Roche, Jean‐Pascal Capp, Frédéric Thomas A · 2021 · Frontiers in Oncology
KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway
Wenjing Xu, Liwei Xie, Yingying Yang, Jiayu Xu, Shang Cai, Ye Tian · 2022 · International Journal of Endocrinology
An oncospace for human cancers
Guim Aguadé‐Gorgorió, José C. Costa, Ricard V. Solé · 2023 · BioEssays
The Yin and Yang of Breast Cancer: Ion Channels as Determinants of Left–Right Functional Differences
Sofía Masuelli, Sebastián Real, Patrick T. McMillen, Madeleine Julie Oudin, Michael G. Levin, María Roqué · 2023 · International Journal of Molecular Sciences
Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma
Jiajing Wang, Jianfeng Shu · 2023 · Current Medicinal Chemistry
Chemical-genetics refines transcription factor regulatory circuits
Hillary M. Layden, Anna E. Johnson, Scott W. Hiebert · 2023 · Trends in cancer
Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, Giuliana Cassinelli · 2024 · Biochemical Pharmacology
A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin
Sean M. Santos, John L. Hartman · 2019 · Cancer & Metabolism
Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression
Joonas Uusi-Mäkelä, Ebrahim Afyounian, Francesco Tabaro, Tomi Häkkinen, Alessandro Lussana, Anastasia Shcherban, Matti Annala, Riikka Nurminen, Kati K. Kivinummi, Teuvo L.J. Tammela et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Editorial: Genetic and Epigenetic Control of Immune Responses
Satish Kumar Reddy Noonepalle, Lidia Karabon, Katherine Bakshian Chiappinelli, Alejandro Villagra · 2021 · Frontiers in Immunology
A guide to epigenetics in leukaemia stem cells
Shuchi Agrawal Singh, Jaana Bagri, Nathalie Sakakini, Brian J.P. Huntly · 2023 · Molecular Oncology
Citrullinating enzyme PADI4 and transcriptional repressor RING1B bind in cancer cells
Salomé Araujo‐Abad, Bruno Rizzuti, Lourdes Soto-Conde, Miguel Vidal, Olga Abián, Adrián Velázquez‐Campoy, José L. Neira, Camino de Juan Romero · 2024 · International Journal of Biological Macromolecules
Transcriptomic era of cancers in females: new epigenetic perspectives and therapeutic prospects
Runhe Zhu, Jiawei Ni, Jiayin Ren, Dongye Li, Jiawei Xu, Xinru Yu, Ying Jie Ma, Luan Kou · 2024 · Frontiers in Oncology
Chemical catalyst manipulating cancer epigenome and transcription
Yuki Yamanashi, Shinpei Takamaru, Atsushi Okabe, Satoshi Kaito, Yuto Azumaya, Yugo R. Kamimura, Kenzo Yamatsugu, Tomoya Kujirai, Hitoshi Kurumizaka, Atsushi Iwama et al. · 2025 · Nature Communications
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
Subhasree Kumar, Lev M. Kats, Emily Gruber · 2025 · International Journal of Cancer
YEATS2: a novel cancer epigenetic reader and potential therapeutic target
Kangkang Ji, Guoping Chen, Yan Wang, Yunyi Li, Jian Chen, Mingqian Feng · 2025 · Cancer Cell International
The multitalented TIP60 chromatin remodeling complex: wearing many hats in epigenetic regulation, cell division and diseases
Maria Virginia Santopietro, Diego Ferreri, Yuri Prozzillo, Patrizio Dimitri, Giovanni Messina · 2025 · Epigenetics & Chromatin
Thymic epithelial cells amplify epigenetic noise to promote immune tolerance
Noah Gamble, Jason A. Caldwell, Joshua A. McKeever, Caroline Kaiser, Alexandra Bradu, Peyton J. Dooley, Sandy L. Klemm, William James Greenleaf, Narutoshi Hibino, Aaron R. Dinner et al. · 2025 · Nature
Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications
Bárbara Bueloni, Maite G. Fernández‐Barrena, Esteban Juan Fiore, Matias Antonio Avila, Juan Bayo, Guillermo Daniel Mazzolini · 2025 · Gut
Mechanistically informed machine learning links non-canonical TCA cycle activity to Warburg metabolism and hallmarks of malignancy
Lin Lihao, Lapi Francesco, Bruno G. Galuzzi, Marco Vanoni, Lilia Alberghina, Chiara Damiani · 2025 · PLoS Computational Biology
Individual cell‐based modeling of tumor cell plasticity‐induced immune escape after CAR‐T therapy
Can Zhang, Changrong Shao, Xiaopei Jiao, Yue Yu Bai, Miao Li, Hanping Shi, Jinzhi Lei, Xiaosong Zhong · 2021 · Computational and Systems Oncology
Mechanisms of Survival of Cytomegalovirus-Infected Tumor Cells
G. R. Vinogradskaya, Alexander V. Ivanov, Kushch Aa · 2022 · Molecular Biology
Significance of exosomes in hepatocellular carcinoma
GuoYun Wang, Gaixiang Luo, MeiJing Zhao, Huilai Miao · 2022 · Frontiers in Oncology
Transcriptome and methylome sequencing reveals altered long non-coding RNA genes expression and their aberrant DNA methylation in equine sarcoids
Ewelina Semik‐Gurgul, Artur Gurgul, Tomasz Szmatoła · 2023 · Functional & Integrative Genomics
Cla4 phosphorylates histone methyltransferase Set1 to prevent its degradation by the APC/C Cdh1 complex
Xuanyunjing Gong, Shanshan Wang, Qi Yu, Min Wang, Feng Ge, Shanshan Li, Xilan Yu · 2023 · Science Advances
Heterogeneity and individualized treatment of microenvironment in glioblastoma (Review)
Wei Kang, Zhixiao Mo, Wenshan Li, Haifeng Ma, Qiang Zhang · 2023 · Oncology Reports